SCHEMBL4256095

SCHEMBL4256095

O=C(Nc1ccc(F)cc1)c1cc(Cl)[nH]n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.51
ALOX15 P16050 3/20 0.51
RAB9A P51151 4/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
NPC1 O15118 3/20 0.49
P2RX1 P51575 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
CDK2 P24941 2/20 0.48
KDM4E B2RXH2 1/20 0.48
RXFP1 Q9HBX9 1/20 0.47
MAPT P10636 1/20 0.47
KCNQ3 O43525 1/20 0.47
KCNQ2 O43526 1/20 0.47
KCNE1 P15382 1/20 0.47
KCNQ1 P51787 1/20 0.47
BACE1 P56817 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4256925 0.87 NPC1 (0.51) MEN1KMT2ASMN1; SMN2ALOX15RAB9A
SCHEMBL29699826 0.83 MEN1 (0.62) MEN1KMT2ASMN1; SMN2ALOX15RAB9A
SCHEMBL4252112 0.81 ALOX15 (0.78) KMT2AALOX15
SCHEMBL4250340 0.81 ALOX15 (0.61) SMN1; SMN2ALOX15RAB9AHTTNPC1
SCHEMBL4187822 0.80 GRM5 (0.51) SMN1; SMN2ALOX15RAB9ANPC1ALDH1A1
SCHEMBL168618 0.74 MEN1 (0.63) MEN1KMT2ASMN1; SMN2RAB9AMAPK1
SCHEMBL8694108 0.73 CDK2 (0.64) MEN1KMT2ACDK2MAPT
SCHEMBL3231560 0.72 KCNQ3 (0.54) MEN1KMT2ASMN1; SMN2RAB9AMAPK1
SCHEMBL6874915 0.71 NPC1 (0.69) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL16006837 0.71 RAB9A (0.66) MEN1KMT2ASMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143455-A1 Pyrazoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143455-A1 Pyrazoles Useful in the Treatment of Inflammation ALOX15, ALOX12, ALOX15B MEN1 4032/4885KMT2A 4432/4885SMN1; SMN2 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.